-
-
Overview
-
D1-D2 heteromer antagonist.
Tat-D1 peptide is a peptide constructed from amino acids 396 413 of the dopamine D1 receptor C tail – a sequence chosen to include amino acids 404Glu and 405Glu which were identified to interact with the dopamine D2 receptor – fused at the NH2 terminus to TAT peptide for cell permeability. TAT-D1 peptide blocks the interaction between D1 and D2 receptors, inhibiting D1-D2 heteromer expression and function without affecting other receptor oligomers such as D1-D1 homomers or D2-D5 heteromers. Tat-D1 peptide disruption of the D1-D2 heteromer abolishes its interaction with Gq and attenuates its calcium signalling and functions as a selective antagonist in vitro and in vivo. In animal models, TAT-D1 treatment alleviates behavioural despair symptoms and exerts antidepressant-like effects in rats, and in addiction models the Tat-D1 peptide reverses SKF83959-induced inhibition of amphetamine sensitization.
Please contact us for availability.Please contact us at for specific academic pricing.
-
- Properties
-
Overview